Angel Yeast Scales AngeoPro as China Battles 45% Adult Dietary Protein Deficit
With 45% of Chinese adults failing to meet dietary protein requirements, Angel Yeast is expanding its 50,000-tonne microbial fermentation capacity. The supplier's AngeoPro ingredient provides manufacturers with a high-purity, lactose-free alternative to imported whey and soy.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Beijing, China — 21 July 2026
Data from long-term monitoring by the Chinese Center for Disease Control and Prevention (China CDC) indicates that 45% of Chinese adults fail to achieve adequate dietary protein intake, despite overall national consumption holding steady over four decades. Chronic deficits are concentrated among rural demographics and senior populations. This nutritional deficit exists alongside heavy reliance on overseas supply chains; in 2025, China imported approximately 112 million tonnes of soybeans, 16.73 million tonnes of dairy products, and 6.09 million tonnes of meat.
Expanding domestic supply through conventional livestock farming and field agriculture faces severe limits, including domestic arable land shortages, water constraints, and volatile import tariffs. Speaking at the Growth Asia Summit, Chris Chen, General Manager of Angel Yeast's Nutrition & Health Technology Centre, identified industrial precision fermentation as an essential path to de-risk national food supply.
Angel Yeast is scaling commercial production of its proprietary microbial protein, AngeoPro. Holding clearance as China's first approved microbial protein food ingredient, AngeoPro delivers a protein concentration exceeding 80% alongside a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1.0. In vivo Digestible Indispensable Amino Acid Score (DIAAS) evaluations demonstrate performance close to bovine whey and superior to standard legume isolates. Backed by 50 patents and 22 SCI-indexed research publications, the ingredient delivers high concentrations of branched-chain amino acids, arginine, and lysine, without the bitter off-notes common to traditional yeast extracts.
The manufacturer currently runs three industrial fermentation lines across three Chinese production hubs, maintaining an aggregate capacity exceeding 50,000 tonnes annually across 70% to 90% protein specifications.
What this means for China
For Chinese brand owners, AngeoPro provides an insulated domestic ingredient pipeline that bypasses price volatility in imported dairy proteins and trade risks surrounding imported soy. Formulators targeting senior health, clinical nutrition, and sports nutrition can deploy the ingredient to create clean-label, lactose-free functional powders with neutral sensory profiles, avoiding the beany off-notes that complicate plant-based formulations. Because the ingredient holds domestic novel food clearance, regulatory timelines for consumer finished goods are streamlined. However, with aggregate production currently capped at 50,000 tonnes across three facilities, procurement leads must secure firm allocation contracts early as commercial demand across functional food and RTD categories accelerates.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.
This article does not constitute medical advice.